1,086 results on '"Gunn, Roger"'
Search Results
2. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of SV2A
3. Estimation of target occupancy in repeated dosing design studies using positron emission tomography: Biases due to target upregulation
4. PET Parametric Imaging: Past, Present, and Future
5. Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study
6. Brain Serotonin Release Is Reduced in Patients With Depression: A [11C]Cimbi-36 Positron Emission Tomography Study With a d-Amphetamine Challenge
7. Application of Aligned-UMAP to longitudinal biomedical studies
8. GANsfer Learning: Combining labelled and unlabelled data for GAN based data augmentation
9. Principles of PET and Its Role in Understanding Drug Delivery to the Brain
10. Endogenous dopamine release in the human brain as a pharmacodynamic biomarker: evaluation of the new GPR139 agonist TAK-041 with [11C]PHNO PET
11. GAN Augmentation: Augmenting Training Data using Generative Adversarial Networks
12. Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals
13. Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load
14. Principles of PET and Its Role in Understanding Drug Delivery to the Brain
15. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
16. Tau pathology in early Alzheimer's disease is linked to selective disruptions in neurophysiological network dynamics
17. The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
18. The relationship between SV2A levels, neural activity, and cognitive function in healthy humans: A [11C]UCB-J PET and fMRI study
19. Estimating Braak stage from [18F]MK6240 PET scans
20. Estimation of target occupancy in repeated dosing design studies using positron emission tomography: Biases due to target upregulation
21. The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
22. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals
23. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats
24. Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)
25. Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge
26. Preclinical evaluation of [18F]FB-A20FMDV2 as a selective marker for measuring αVβ6 integrin occupancy using positron emission tomography in rodent lung
27. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
28. Accuracy and reliability of [11C]PBR28 specific binding estimated without the use of a reference region
29. Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
30. Reproducibility of findings in modern PET neuroimaging: insight from the NRM2018 grand challenge
31. Confirmation of Specific Binding of the 18-kDa Translocator Protein (TSPO) Radioligand [18F]GE-180: a Blocking Study Using XBD173 in Multiple Sclerosis Normal Appearing White and Grey Matter
32. Disease-related patterns of in vivo pathology in Corticobasal syndrome
33. Synaptic Terminal Density Early in the Course of Schizophrenia: An In Vivo UCB-J Positron Emission Tomographic Imaging Study of Synaptic Vesicle Glycoprotein 2A
34. Pseudo-healthy Image Synthesis for White Matter Lesion Segmentation
35. Imaging in Central Nervous System Drug Discovery
36. Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
37. Guidelines for the content and format of PET brain data in publications and archives: A consensus paper
38. Synaptic terminal density early in the course of schizophrenia: an in vivo UCB-J positron emission tomographic imaging study of synaptic vesicle glycoprotein 2A (SV2a)
39. A PET-CT study on neuroinflammation in Huntington’s disease patients participating in a randomized trial with laquinimod
40. Quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflammation
41. Concurrent 3D super resolution on intensity and segmentation maps improves detection of structural effects in neurodegenerative disease
42. Mathematical modelling and identifiability applied to positron emission tomography data
43. Principles of PET and Its Role in Understanding Drug Delivery to the Brain
44. Imaging Type 1 Glycine Transporters in the CNS Using Positron Emission Tomography
45. Building a database for brain 18 kDa translocator protein imaged using [11C]PBR28 in healthy subjects
46. Quantification of human brain PDE4 occupancy by GSK356278: A [11C](R)-rolipram PET study
47. Application of Aligned-UMAP to longitudinal biomedical studies
48. PROGRESS IN DEVELOPING A LIGHT‐STABLE 4R TAU PET IMAGING AGENT: APN‐1701 FIH
49. In Vivo Head‐To‐Head Comparison of [ 18 F]GTP1 and [ 18 F]PI2620 in Alzheimer’s Disease
50. Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.